182 related articles for article (PubMed ID: 12438952)
1. Hematologic aspects of liver transplantation for Budd-Chiari syndrome with special reference to myeloproliferative disorders.
Melear JM; Goldstein RM; Levy MF; Molmenti EP; Cooper B; Netto GJ; Klintmalm GB; Stone MJ
Transplantation; 2002 Oct; 74(8):1090-5. PubMed ID: 12438952
[TBL] [Abstract][Full Text] [Related]
2. Long-term follow-up of liver transplantation for Budd-Chiari syndrome with antithrombotic therapy based on the etiology.
Chinnakotla S; Klintmalm GB; Kim P; Tomiyama K; Klintmalm E; Davis GL; Trotter JF; Saad R; Landaverde C; Levy MF; Goldstein RM; Stone MJ
Transplantation; 2011 Aug; 92(3):341-5. PubMed ID: 21659946
[TBL] [Abstract][Full Text] [Related]
3. High incidence of recurrence and hematologic events following liver transplantation for Budd-Chiari syndrome.
Cruz E; Ascher NL; Roberts JP; Bass NM; Yao FY
Clin Transplant; 2005 Aug; 19(4):501-6. PubMed ID: 16008595
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcome of liver transplant patients with Budd-Chiari syndrome secondary to myeloproliferative neoplasms.
Potthoff A; Attia D; Pischke S; Mederacke I; Beutel G; Rifai K; Deterding K; Heiringhoff K; Klempnauer J; Strassburg CP; Manns MP; Bahr MJ
Liver Int; 2015 Aug; 35(8):2042-9. PubMed ID: 25736096
[TBL] [Abstract][Full Text] [Related]
5. Budd-Chiari syndrome: long term success via hepatic decompression using transjugular intrahepatic porto-systemic shunt.
Zahn A; Gotthardt D; Weiss KH; Richter G; Schmidt J; Stremmel W; Sauer P
BMC Gastroenterol; 2010 Mar; 10():25. PubMed ID: 20193077
[TBL] [Abstract][Full Text] [Related]
6. Eighteen years of liver transplantation experience in patients with advanced Budd-Chiari syndrome.
Ulrich F; Pratschke J; Neumann U; Pascher A; Puhl G; Fellmer P; Weiss S; Jonas S; Neuhaus P
Liver Transpl; 2008 Feb; 14(2):144-50. PubMed ID: 18236386
[TBL] [Abstract][Full Text] [Related]
7. Portosystemic shunt versus orthotopic liver transplantation for the Budd-Chiari syndrome.
Shaked A; Goldstein RM; Klintmalm GB; Drazan K; Husberg B; Busuttil RW
Surg Gynecol Obstet; 1992 Jun; 174(6):453-9. PubMed ID: 1595020
[TBL] [Abstract][Full Text] [Related]
8. Reassessing the role of medical therapy in the management of hepatic vein thrombosis.
Min AD; Atillasoy EO; Schwartz ME; Thiim M; Miller CM; Bodenheimer HC
Liver Transpl Surg; 1997 Jul; 3(4):423-9. PubMed ID: 9346773
[TBL] [Abstract][Full Text] [Related]
9. Myeloproliferative neoplasms and recurrent thrombotic events in patients undergoing liver transplantation for Budd-Chiari syndrome: a single-center experience.
Oldakowska-Jedynak U; Ziarkiewicz M; Ziarkiewicz-Wróblewska B; Dwilewicz-Trojaczek J; Górnicka B; Nyckowski P; Paluszkiewicz R; Wróblewski T; Zieniewicz K; Patkowski W; Pączek L; Jedrzejczak WW; Krawczyk M
Ann Transplant; 2014 Nov; 19():591-7. PubMed ID: 25394736
[TBL] [Abstract][Full Text] [Related]
10. Treatment of the Budd-Chiari syndrome with orthotopic liver transplantation and long-term anticoagulation.
Knoop M; Lemmens HP; Bechstein WO; Blumhardt G; Schattenfroh N; Keck H; Neuhaus P
Clin Transplant; 1994 Feb; 8(1):67-72. PubMed ID: 8136572
[TBL] [Abstract][Full Text] [Related]
11. Primary Budd-Chiari syndrome - a single center experience.
Raszeja-Wyszomirska J; Mieżyńska-Kurtycz J; Marlicz W; Lawniczak M; Wójcicki M
Hepatogastroenterology; 2012 Sep; 59(118):1879-82. PubMed ID: 22819909
[TBL] [Abstract][Full Text] [Related]
12. Transjugular intrahepatic portosystemic shunt (TIPS) for Budd-Chiari syndrome or portal vein thrombosis: review of indications and problems.
Ganger DR; Klapman JB; McDonald V; Matalon TA; Kaur S; Rosenblate H; Kane R; Saker M; Jensen DM
Am J Gastroenterol; 1999 Mar; 94(3):603-8. PubMed ID: 10086638
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of advanced Budd-Chiari syndrome by liver transplantation].
Knoop M; Lang M; Neumann U; Bechstein WO; Neuhaus P
Chirurg; 1998 Dec; 69(12):1362-8. PubMed ID: 10023564
[TBL] [Abstract][Full Text] [Related]
14. Successful liver transplantation in a patient with Budd-Chiari syndrome caused by homozygous factor V Leiden.
Tan HP; Markowitz JS; Maley WR; Merritt WT; Klein AS
Liver Transpl; 2000 Sep; 6(5):654-6. PubMed ID: 10980068
[TBL] [Abstract][Full Text] [Related]
15. [Oral contraceptives and blood diseases are the most common causes of Budd-Chiari syndrome].
Almer S; Bodemar G; Rydén BO; Elfström J; Franzén L; Ihse I; Resjö M
Lakartidningen; 1989 Nov; 86(46):4002-8. PubMed ID: 2511387
[TBL] [Abstract][Full Text] [Related]
16. Prevention of recurrent thrombosis following liver transplantation for Budd-Chiari syndrome associated with myeloproliferative disorders: treatment with hydroxyurea and aspirin.
Goldstein R; Clark P; Klintmalm G; Husberg B; Gonwa T; Stone M
Transplant Proc; 1991 Feb; 23(1 Pt 2):1559-60. PubMed ID: 1989289
[No Abstract] [Full Text] [Related]
17. Liver transplantation for Budd-Chiari syndrome.
Srinivasan P; Rela M; Prachalias A; Muiesan P; Portmann B; Mufti GJ; Pagliuca A; O'Grady J; Heaton N
Transplantation; 2002 Mar; 73(6):973-7. PubMed ID: 11923703
[TBL] [Abstract][Full Text] [Related]
18. Familial polycythemia vera with Budd-Chiari syndrome in childhood.
Cario H; Pahl HL; Schwarz K; Galm C; Hoffmann M; Burdelski M; Kohne E; Debatin KM
Br J Haematol; 2003 Oct; 123(2):346-52. PubMed ID: 14531919
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Budd-Chiari syndrome in a liver transplant unit, the role of transjugular intrahepatic porto-systemic shunt and liver transplantation.
Attwell A; Ludkowski M; Nash R; Kugelmas M
Aliment Pharmacol Ther; 2004 Oct; 20(8):867-73. PubMed ID: 15479358
[TBL] [Abstract][Full Text] [Related]
20. Direct intrahepatic portocaval shunt for treatment of portal thrombosis and Budd-Chiari syndrome.
Pedersen MR; Molloy P; Wood D; Seetharam A
Ann Hepatol; 2016; 15(1):127-30. PubMed ID: 26626649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
